Nasdaq IPOs See Mixed Biotech Reception
In a busy week for life sciences IPOs, most biotech debuts saw a positive reception. Online recruitment platform, HeadHunter Group, posted an advance as it marked the first Russian IPO on an Exchange in the U.S. since 2013.
Advances in global biotech offer exciting opportunities
Innovative biotechnology companies — based both in and outside the United States — represent an exciting opportunity set, says portfolio manager Rob Lovelace.